The average one-year price target for Veradermics (NYSE:MANE) has been revised to $92.14 / share. This is an increase of 15.32% from the prior estimate of $79.90 dated April 12, 2026.
The price target is an average of many targets provided by analysts. The latest targets range from a low of $75.75 to a high of $116.55 / share. The average price target represents a decrease of 10.63% from the latest reported closing price of $103.10 / share.
What are Other Shareholders Doing?
Private Advisor Group holds 5K shares representing 0.01% ownership of the company.
Nvwm holds 0K shares representing 0.00% ownership of the company.
SBI Securities Co. holds 0K shares representing 0.00% ownership of the company.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
